Kennedy's advisory panel is expected to vote on hepatitis B and MMRV vaccines Updated 13 mins ago Health Secretary Robert F. Kennedy Jr.'s new vaccine advisory committee kicked off a two-day session on Thursday. The morning’s discussion focused on a combination vaccine called MMRV, which protects against measles, mumps, rubella and chickenpox, which is also known as varicella. Members talked about rare instances of feverish seizures that have been associated with the first dose, given to kids between ages 1 and 2. Votes are expected in the afternoon on this vaccine and a hepatitis B shot given to newborns shortly after birth. The committee will make COVID-19 vaccine recommendations on Friday.

See Full Page